• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长效可逆避孕法。使用TCu380A和TCu220C的十二年经验。

Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.

出版信息

Contraception. 1997 Dec;56(6):341-52.

PMID:9494767
Abstract

Few data on the long-term efficacy of intrauterine devices (IUD) are available, and this article reports on the final 12-year experience with the TCu220C and TCu380A devices from two randomized, multicenter trials conducted in 24 centers. A total of 3,277 and 1,396 women, respectively, were recruited for use of each device between 1981 and 1986 and followed at 3, 6, and 12 months after insertion and yearly thereafter. At the end of 12 years, a total of 17,098 women-years of experience had been accumulated for the TCu220C and 7,159 women-years for the TCu380A. The cumulative 12-year intrauterine pregnancy rates were 7.0 (standard error [SE] 0.6) per 100 women for the TCu220C and 1.9 (SE 0.5) for the TCu380A (p < 0.001). Pregnancy rates were highest in the first years after insertion; the TCu220C had a consistently higher annual pregnancy rate than did the TCu380A at all intervals since insertion. No pregnancies were reported with the TCu380A after 8 years of use. Total medical removals were approximately 6% in the first year and dropped to approximately 4% per year for each device for up to 12 years of use (cumulative 12 year rates were 37.3 [SE 1.3] and 40.2 [SE 2.1] per 100 women for the TCu220C and TCu380A devices, respectively). The overall continuation rate at all intervals since insertion was higher with the TCu220C device, mainly due to higher removal rates for nonmedical reasons with the TCu380A. The cumulative ectopic pregnancy rates were 0.7 and 0.4 for the TCu220C and TCu380A, respectively. Pregnancy rates were higher in the Chinese compared with the non-Chinese centers for both devices, though the greater efficacy of the TCu380A was apparent in both groups of centers. The total medical and nonmedical removal rates were lower in the Chinese compared with the non-Chinese centers, and did not show any substantial differences between the devices. We conclude that both devices are safe and effective for at least 12 years of use and the low pregnancy rate with the TCu380A is comparable with that reported in the United States among women who had undergone tubal sterilization. The very high efficacy of the TCu380A makes it the IUD of choice, and it can be considered as a potentially reversible, non-surgical alternative to sterilization for women requiring very long-term pregnancy protection.

摘要

关于宫内节育器(IUD)长期疗效的数据较少,本文报告了在24个中心进行的两项随机、多中心试验中使用TCu220C和TCu380A装置的最终12年经验。1981年至1986年期间,分别招募了3277名和1396名女性使用每种装置,并在插入后3个月、6个月和12个月以及此后每年进行随访。在12年结束时,TCu220C累计积累了17098妇女年的经验,TCu380A累计积累了7159妇女年的经验。TCu220C每100名妇女的12年累计宫内妊娠率为7.0(标准误[SE]0.6),TCu380A为1.9(SE 0.5)(p<0.001)。妊娠率在插入后的头几年最高;自插入以来,在所有时间段内,TCu220C的年妊娠率始终高于TCu380A。使用TCu380A 8年后未报告妊娠。两种装置在第一年的总医疗取出率约为6%,在长达12年的使用期内每年降至约4%(TCu220C和TCu380A装置每100名妇女的12年累计取出率分别为37.3[SE 1.3]和40.2[SE 2.1])。自插入以来,所有时间段内TCu220C装置的总体持续使用率更高,主要是因为TCu380A因非医疗原因的取出率更高。TCu220C和TCu380A的累计宫外孕率分别为0.7和0.4。两种装置在中国中心的妊娠率均高于非中国中心,尽管TCu380A在两组中心的疗效均更显著。中国中心的总医疗和非医疗取出率低于非中国中心,且两种装置之间未显示出任何实质性差异。我们得出结论,两种装置在至少12年的使用期内都是安全有效的,TCu380A的低妊娠率与美国输卵管绝育妇女中报告的妊娠率相当。TCu380A的极高疗效使其成为首选的宫内节育器,对于需要长期妊娠保护的女性,它可被视为一种潜在的可逆、非手术绝育替代方法。

相似文献

1
Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.长效可逆避孕法。使用TCu380A和TCu220C的十二年经验。
Contraception. 1997 Dec;56(6):341-52.
2
[A multicentre comparative clinical study of uterine cavity shaped device Cu300, TCu220C and TCu380A in ten years].
Zhonghua Fu Chan Ke Za Zhi. 2003 May;38(5):298-301.
3
The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.无支架铜宫内节育器(吉妮柔适)与TCu380A宫内节育器:一项8年多中心随机对照试验的结果。
Contraception. 2009 Aug;80(2):133-41. doi: 10.1016/j.contraception.2009.02.006. Epub 2009 Mar 31.
4
Intrauterine devices: an effective alternative to oral hormonal contraception.宫内节育器:口服激素避孕的有效替代方法。
Prescrire Int. 2009 Jun;18(101):125-30.
5
IUDs safe and effective at nine years of continuous use.
Prog Hum Reprod Res. 1992(22):2-3.
6
[Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].[含药不锈钢环-165、含药γ型宫内节育器与TCu220C:一项多中心比较研究]
Zhonghua Fu Chan Ke Za Zhi. 1997 Feb;32(2):97-101.
7
Continuation rates and reasons for discontinuing TCu380A IUD use in Tabriz, Iran.伊朗大不里士地区TCu380A宫内节育器的续用率及停用原因
Contraception. 2006 Dec;74(6):483-6. doi: 10.1016/j.contraception.2006.08.007. Epub 2006 Oct 13.
8
Intrauterine devices. The optimal long-term contraceptive method?宫内节育器。最佳的长期避孕方法?
J Reprod Med. 1999 Mar;44(3):269-74.
9
Experience with the Copper-7 and Copper-T intrauterine devices at Siriraj Hospital in Bangkok, Thailand.泰国曼谷诗里拉吉医院使用铜-7和铜-T宫内节育器的经验。
J Med Assoc Thai. 1982 Jan;65(1):12-7.
10
[Copper-7 intrauterine device (Gravigard). Report of experience].[含铜 7 宫内节育器(Gravigard)。经验报告]
Fortschr Med. 1976 Mar 18;94(9):515-21.

引用本文的文献

1
Extended duration of use of long-acting reversible contraceptives: Systematic review.长效可逆避孕药的延长使用期限:系统评价
Can Fam Physician. 2025 Feb;71(2):e35-e52. doi: 10.46747/cfp.7102e35.
2
Contraceptive Care in the Rheumatic Diseases: A Review.风湿性疾病中的避孕护理:综述。
J Clin Rheumatol. 2024 Oct 1;30(7S Suppl 1):S5-S12. doi: 10.1097/RHU.0000000000002124.
3
Retained Copper Intrauterine Device Fragment in Pregnancy: A Case Report.妊娠期间残留的宫内节育器碎片:一例报告
Cureus. 2022 Dec 14;14(12):e32537. doi: 10.7759/cureus.32537. eCollection 2022 Dec.
4
Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response.计划生育协会临床建议:大流行应对背景下的避孕护理。
Contraception. 2022 Sep;113:1-12. doi: 10.1016/j.contraception.2022.05.006. Epub 2022 May 18.
5
Contraceptive counseling during the pandemic: practical guidelines.疫情期间的避孕咨询:实用指南
Rev Bras Ginecol Obstet. 2021 Jul;43(7):579-584. doi: 10.1055/s-0041-1735185. Epub 2021 Aug 30.
6
Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study.新型铜宫内节育器使用者的出血、痉挛和满意度:一项前瞻性研究。
PLoS One. 2018 Nov 7;13(11):e0199724. doi: 10.1371/journal.pone.0199724. eCollection 2018.
7
Postpartum Intrauterine Device Refusal in Delhi: Reasons Analyzed.德里产后宫内节育器的拒绝情况:原因分析
J Obstet Gynaecol India. 2018 Jun;68(3):208-213. doi: 10.1007/s13224-015-0714-9. Epub 2015 Jul 14.
8
New developments in intrauterine device use: focus on the US.宫内节育器使用的新进展:聚焦美国。
Open Access J Contracept. 2016 Sep 13;7:127-141. doi: 10.2147/OAJC.S85755. eCollection 2016.
9
Long-Acting Reversible Contraception.长效可逆避孕法
Rev Bras Ginecol Obstet. 2017 Jun;39(6):294-308. doi: 10.1055/s-0037-1603647. Epub 2017 Jul 3.
10
Contraceptive failure with Copper T380A intrauterine device (IUD): A single tertiary center experience.含铜T380A宫内节育器(IUD)避孕失败:一家三级中心的单中心经验。
Pak J Med Sci. 2016 Sep-Oct;32(5):1087-1091. doi: 10.12669/pjms.325.10392.